Justin Townsend is the CEO and Head Facilitator of MycoMeditations, a psilocybin wellness center in Jamaica that offers week-long magic mushroom retreats....
Peyton Nyquvest is the CEO of Numinus, a Canadian publicly-traded company that is involved in psychedelic synthesis, research and treatment. Numinous recently...
In our continuing conversation with Chris Wink, co-founder of Blue Man Group and creator of the psychedelic art exhibit Wink World, we discuss the nature...
This is the first article in a series investigating the Church of Psilomethoxin (CoP), exploring the recent debate about the Church's sacrament and the...
In the illustrious world of self-proclaimed investment gurus, few figures cast a longer shadow than Kevin O’Leary. This Canadian entrepreneur, The post...
Cybin Inc. (NEO:CYBN / NYSE American:CYBN) a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new...
The article LSD for Depression: A Closer Look was originally published on Microdose. As the search for effective treatments for depression continues,...
Executive Director William Garner now owns or exercises control over nearly 40% of common shares. The post Tryp Therapeutics Raises AUD$2.4 Million appeared...
Breaking Convention in Exeter is the indie label equivalent to the corporadelic mega conventions taking over across the psychedelic realm, with equal emphasis...
The article Microdosing LSD: Exploring Sub-Perceptual Doses was originally published on Microdose. In recent years, the practice of microdosing LSD (and...